These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 38066252
21. Eligibility for 177Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of 68Ga-PSMA-11 and 99mTc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer. Cook GJR, Wong WL, Sanghera B, Mangar S, Challapalli A, Bahl A, Bassett P, Leaning D, Schmidkonz C. J Nucl Med; 2023 Feb; 64(2):227-231. PubMed ID: 36302657 [Abstract] [Full Text] [Related]
22. Preliminary application of micro-SPECT/CT imaging by 99m Tc-tricine-EDDA-HYNIC-c-Met for non-small-cell lung cancer. Zhang Y, Meng L, Li B, Tan H, Lin QY, Cheng D, Shi H. Chem Biol Drug Des; 2019 Apr; 93(4):447-453. PubMed ID: 30381892 [Abstract] [Full Text] [Related]
23. Synthesis and Evaluation of 99mTc-Labeled DPro-Gly-Containing Tracers Targeting PSMA. Li Z, Jiang Y, Ruan Q, Yin G, Han P, Duan X, Zhang J. Mol Pharm; 2024 Oct 07; 21(10):5305-5314. PubMed ID: 39298677 [Abstract] [Full Text] [Related]
24. Synthesis, radiolabeling and evaluation of [99mTc][Tc-HYNIC/EDDA]-Met(O) as a early agent for amino acid metabolic imaging in C6 glioblastoma tumor. Dinmohammadi F, Erfani M, Shamsaei M, Shirmardi SP, Goudarzi M. Bioorg Chem; 2023 Jan 07; 130():106237. PubMed ID: 36402025 [Abstract] [Full Text] [Related]
25. Radiation Dosimetry of 99mTc-PSMA I&S: A Single-Center Prospective Study. Urbán S, Meyer C, Dahlbom M, Farkas I, Sipka G, Besenyi Z, Czernin J, Calais J, Pávics L. J Nucl Med; 2021 Aug 01; 62(8):1075-1081. PubMed ID: 33277398 [Abstract] [Full Text] [Related]
26. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer. Yang X, Li G, Ruan C, Hu K, Tang G. Bioconjug Chem; 2023 Nov 15; 34(11):2133-2143. PubMed ID: 37874952 [Abstract] [Full Text] [Related]
27. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma. Guo H, Miao Y. J Nucl Med; 2014 Dec 15; 55(12):2057-63. PubMed ID: 25453052 [Abstract] [Full Text] [Related]
28. 99mTc-labeling and evaluation of a HYNIC modified small-molecular inhibitor of prostate-specific membrane antigen. Xu X, Zhang J, Hu S, He S, Bao X, Ma G, Luo J, Cheng J, Zhang Y. Nucl Med Biol; 2017 May 15; 48():69-75. PubMed ID: 28273495 [Abstract] [Full Text] [Related]
29. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer. Robu S, Schottelius M, Eiber M, Maurer T, Gschwend J, Schwaiger M, Wester HJ. J Nucl Med; 2017 Feb 15; 58(2):235-242. PubMed ID: 27635024 [Abstract] [Full Text] [Related]
30. An improved 99mTc-HYNIC-(Ser)3-LTVSPWY peptide with EDDA/tricine as co-ligands for targeting and imaging of HER2 overexpression tumor. Khodadust F, Ahmadpour S, Aligholikhamseh N, Abedi SM, Hosseinimehr SJ. Eur J Med Chem; 2018 Jan 20; 144():767-773. PubMed ID: 29291444 [Abstract] [Full Text] [Related]
31. Comparative assessment of a 99mTc labeled H1299.2-HYNIC peptide bearing two different co-ligands for tumor-targeted imaging. Torabizadeh SA, Abedi SM, Noaparast Z, Hosseinimehr SJ. Bioorg Med Chem; 2017 May 01; 25(9):2583-2592. PubMed ID: 28351606 [Abstract] [Full Text] [Related]
32. Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging. Garcia MF, Zhang X, Gallazzi F, Fernandez M, Moreno M, Gambini JP, Porcal W, Cabral P, Quinn TP. Anticancer Agents Med Chem; 2015 May 01; 15(1):122-30. PubMed ID: 25175799 [Abstract] [Full Text] [Related]
33. [99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor. Kaihani S, Sadeghzadeh N, Abediankenari S, Abedi SM. Ann Nucl Med; 2022 Nov 01; 36(11):976-985. PubMed ID: 36097232 [Abstract] [Full Text] [Related]
34. 177Lu-PSMA-617 Therapy in Mice, with or without the Antioxidant α1-Microglobulin (A1M), Including Kidney Damage Assessment Using 99mTc-MAG3 Imaging. Kristiansson A, Örbom A, Ahlstedt J, Karlsson H, Zedan W, Gram M, Åkerström B, Strand SE, Altai M, Strand J, Vilhelmsson Timmermand O. Biomolecules; 2021 Feb 10; 11(2):. PubMed ID: 33579037 [Abstract] [Full Text] [Related]
35. Relationship between PSA kinetics and Tc-99m HYNIC PSMA SPECT/CT detection rates of biochemical recurrence in patients with prostate cancer after radical prostatectomy. Liu C, Zhu Y, Su H, Xu X, Zhang Y, Ye D, Hu S. Prostate; 2018 Dec 10; 78(16):1215-1221. PubMed ID: 30027591 [Abstract] [Full Text] [Related]
36. 99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours. von Guggenberg E, Dietrich H, Skvortsova I, Gabriel M, Virgolini IJ, Decristoforo C. Eur J Nucl Med Mol Imaging; 2007 Aug 10; 34(8):1209-18. PubMed ID: 17308920 [Abstract] [Full Text] [Related]
37. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression. Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R. Nucl Med Biol; 2006 Nov 10; 33(8):945-52. PubMed ID: 17127166 [Abstract] [Full Text] [Related]
38. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer. Hillier SM, Maresca KP, Lu G, Merkin RD, Marquis JC, Zimmerman CN, Eckelman WC, Joyal JL, Babich JW. J Nucl Med; 2013 Aug 10; 54(8):1369-76. PubMed ID: 23733925 [Abstract] [Full Text] [Related]
39. Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen. Kulkarni HR, Singh A, Langbein T, Schuchardt C, Mueller D, Zhang J, Lehmann C, Baum RP. Br J Radiol; 2018 Nov 10; 91(1091):20180308. PubMed ID: 29762048 [Abstract] [Full Text] [Related]
40. Radiolabeled Rhein as Small-Molecule Necrosis Avid Agents for Imaging of Necrotic Myocardium. Luo Q, Jin Q, Su C, Zhang D, Jiang C, Fish AF, Feng Y, Ni Y, Zhang J, Yin Z. Anal Chem; 2017 Jan 17; 89(2):1260-1266. PubMed ID: 27981843 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]